查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2000676

神經血栓除去裝置市場：按器械類型、手術類型、最終用戶和分銷管道分類的全球市場預測，2026-2032年

Neurothrombectomy Devices Market by Device Type, Procedure Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年神經血栓除去裝置市值為 9.9109 億美元，預計到 2026 年將成長至 11.2884 億美元，複合年成長率為 13.74%，到 2032 年將達到 24.4182 億美元。

主要市場統計數據
基準年 2025 991,090,000 美元
預計年份：2026年 1,128,840,000 美元
預測年份 2032 2,441,820,000 美元
複合年成長率 (%) 13.74%

建立臨床、營運和採購基礎，這將影響現代急性中風治療環境中血栓除去裝置的選擇。

在臨床快速應用、手術創新和不斷變化的醫療保健格局的推動下，血栓除去裝置已成為急性中風治療全過程的關鍵所在。本文概述了影響這些裝置設計、採購決策和應用曲線的關鍵技術、臨床因素和相關人員的優先事項。透過將裝置類型置於現代手術方案的背景下，我們闡明了它們的技術特性如何轉化為實際的臨床效用和操作偏好。

這項研究揭示了技術、臨床和系統因素的融合，這些因素正在重塑急性中風治療中的設備設計、部署偏好和策略重點。

隨著技術、臨床和系統性因素的融合，神經血栓切除術領域正經歷變革性的轉變，重新定義了急性缺血性腦中風的治療方法。影像技術的進步和從入院到血流灌注的快速流程的加速，提升了器械輸送性和可追溯性的重要性，促使器械設計不斷改進，優先考慮低輪廓入路、增強導航和提高抽吸性能。同時，臨床證據也不斷完善抽吸優先和聯合治療方案的選擇標準，推動器材製造商投資研發多功能和整合解決方案。

本分析探討了 2025 年的累積關稅環境和貿易政策調整將如何重塑所有利害關係人的供應鏈韌性、籌資策略和定價趨勢。

近期貿易政策的發展以及2025年實施的關稅調整，為血栓除去裝置的全球供應鏈引入了新的變數。其累積影響不僅限於直接的成本增加，還會波及製造地決策、關鍵零件的籌資策略以及跨境分銷的經濟效益。為此，許多製造商正在重新審視其供應商關係，並探索近岸外包、雙重採購以及增加庫存緩衝等措施，以降低關稅相關的波動風險。這些變化正在對採購計劃以及與醫院和分銷商的合約條款產生後續影響。

揭示設備、手術、最終用戶和分銷環節之間的細微差異，這些差異決定了整個神經血栓切除解決方案市場的臨床適用性、採購偏好和商業性定位。

分析細分市場層面的趨勢揭示了因器械類型、手術方法、終端用戶環境和通路而異的微妙機會和限制因素。在器械類型細分方面，抽吸導管根據內徑大小進一步細分，中等直徑的導管強調其在彎曲解剖結構內的柔軟性和導航性，而大直徑導管則優先考慮抽吸能力，以實現快速血栓切除。組合系統涵蓋範圍廣泛，從將抽吸和取栓功能整合於單一工作流程中的完全整合平台，到允許臨床醫生在複雜病例中組合頂級組件的獨立輔助解決方案。血栓摘取支架也分為塗層和非塗層兩種設計，表面處理會影響血栓與器械的相互作用和輸送特性。

本檢驗了美洲、歐洲、中東、非洲和亞太地區的區域差異如何為醫療設備相關人員帶來獨特的臨床、監管和商業性需求。

區域趨勢影響著美洲、歐洲、中東和非洲以及亞太地區的臨床實踐、監管預期和商業策略，為市場參與企業帶來了獨特的挑戰。在美洲，成熟的卒中網路和對綜合卒中中心的投資正在推動先進血栓除去裝置的快速普及。同時，地域差異顯著，持續催生了對能夠促進遠距分流和傳輸通訊協定的解決方案的需求。因此，供應商通常會優先考慮全面的服務模式、完善的培訓計劃以及與不同醫療保健系統相關的實證實踐。

本研究評估了從成熟的全球性公司到專業創新者和契約製造等不同類型公司的策略如何塑造其產品藍圖和競爭差異化。

公司層面的發展趨勢反映了各種不同的策略立場，涵蓋了從大規模全球醫療設備公司到靈活的專業研發公司和契約製造。成熟的跨國公司通常透過廣泛的臨床試驗項目、大規模的分銷網路和一體化的服務交付來維持其市場地位，而新興企業專注於透過提高供給能力、獨特的修復機製或針對特定解剖結構或血栓成分的聯合治療來實現利基差異化。為了應對競爭壓力，合作和有針對性的協作正變得越來越普遍，以此來縮短產品上市時間並擴大臨床檢驗範圍。

一項務實的多方相關人員策略，將產品創新、供應鏈韌性和實證採購相結合，以實現永續的臨床部署和競爭優勢。

產業領導者應採取多維策略，將產品創新、供應鏈穩健性和相關人員為中心的商業模式結合。製造商應優先發展模組化設備組合，使臨床醫生能夠根據手術的複雜程度選擇合適的設備，同時保持生產規模經濟效益。此外，供應商多元化以及考慮區域組裝和製造地，有助於降低關稅波動帶來的風險，並提高對當地採購週期的應對力。

採用多層次的研究途徑，結合對臨床專家的訪談、監管和程序文獻以及供應鏈分析，以確保檢驗且可操作的見解。

本研究採用多層次調查方法，整合定性和定量訊息，旨在平衡臨床相關性和操作可行性。主要調查包括對介入性神經放射科醫生、神經外科醫生、中風計畫主任、醫院採購負責人和分銷主管進行結構化訪談，以了解手術偏好、採購標準和供應鏈限制。次要調查涵蓋同儕審查的臨床研究、監管申報文件、醫療設備附加檔和公開的手術指南，以支持有關臨床表現和實踐模式的論點。

該摘要強調了臨床表現、營運韌性和實證商業化如何決定神經血栓切除術的長期成功。

總之，我們總結了技術創新、流程改善和近期貿易趨勢如何共同影響整個神經血栓切除術生態系統的策略決策。在快速再灌注和簡化工作流程日益重要的治療路徑中，能夠顯著提高首過效應、簡化操作流程和實現跨平台相容性的器械將保持競爭優勢。同時，價值鏈上的關稅壓力凸顯了生產彈性、多元化採購和增值分銷模式在維持服務連續性方面的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：神經血栓除去裝置市場：依器材類型分類

  • 吸痰管
    • 中間內徑
    • 大直徑
  • 複合系統
    • 整合系統
    • 獨立輔助設備
  • 血栓摘取支架
    • 塗層
    • 無塗層

第9章 依治療類型分類的神經血栓除去裝置市場

  • 抽吸血栓切除手術
  • 綜合方法
    • 按順序
    • 同時
  • 機械血栓切除術

第10章：神經血栓除去裝置市場：依最終用戶分類

  • 門診手術中心
  • 醫院
    • 綜合卒中中心
    • 初級卒中中心
  • 專科神經科中心

第11章：神經血栓除去裝置市場：按分銷管道分類

  • 直銷
  • 電子商務
  • 第三方經銷商
    • 獨立銷售代理
    • 加值銷售代理

第12章 神經血栓除去裝置市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：神經血栓除去裝置市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 神經血栓除去裝置市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國血栓除去裝置市場

第16章：中國血栓除去裝置市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Acandis GmbH & Co. KG
  • Boston Scientific Corporation
  • Imperative Care, Inc.
  • Johnson & Johnson
  • Medtronic plc
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-8C74ADFC1598

The Neurothrombectomy Devices Market was valued at USD 991.09 million in 2025 and is projected to grow to USD 1,128.84 million in 2026, with a CAGR of 13.74%, reaching USD 2,441.82 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 991.09 million
Estimated Year [2026] USD 1,128.84 million
Forecast Year [2032] USD 2,441.82 million
CAGR (%) 13.74%

Establishing the clinical, operational, and procurement foundations that shape neurothrombectomy device choices across contemporary acute stroke care settings

Neurothrombectomy devices have become a pivotal focal point across acute stroke care pathways, driven by rapid clinical adoption, procedural innovations, and evolving care settings. This introduction frames the essential technologies, clinical drivers, and stakeholder priorities that shape device design, procurement decisions, and adoption curves. By situating device types within contemporary procedural choices, the narrative clarifies how technical characteristics translate into real-world clinical utility and operational preferences.

Clinicians and health system leaders now confront a landscape where device selection intersects with imaging capabilities, time-to-reperfusion imperatives, and institutional capabilities. As a result, manufacturers are prioritizing ease of use, compatibility with existing cath lab workflows, and consistent clinical performance across variable vascular anatomies. Concurrently, payers and procurement teams emphasize total cost of care and downstream outcomes, prompting a closer alignment between clinical evidence and purchasing strategies.

In this context, the introduction establishes the lens through which subsequent sections examine technological shifts, tariff influences, segmentation-specific dynamics, regional patterns, and company-level strategies. It prepares stakeholders to interpret insights through operational and clinical priorities, and to translate them into actionable plans for product development, market access, and supply chain resilience.

Mapping the converging technological, clinical and system-level forces that are reshaping device design, adoption preferences, and strategic priorities in acute stroke care

The neurothrombectomy landscape is undergoing transformative shifts driven by converging technological, clinical and system-level forces that are redefining how acute ischemic stroke is treated. Imaging advances and faster door-to-reperfusion workflows have elevated the importance of device deliverability and trackability, prompting design iterations that prioritize lower-profile access, improved navigation, and enhanced aspiration performance. At the same time, clinical evidence continues to refine selection criteria for aspiration-first versus combined approaches, encouraging device makers to invest in versatility and integrated solutions.

Operational trends are also reshaping adoption: the expansion of specialized stroke centers, greater emphasis on multidisciplinary stroke teams, and the growth of ambulatory surgical centers where appropriate are influencing device configuration and service offerings. Regulatory pathways and post-market surveillance are adding rigor to performance claims, and manufacturers are responding with clearer clinical registries and real-world evidence programs. Meanwhile, digital augmentation-ranging from procedural planning software to AI-enabled imaging triage-creates opportunities for devices to be positioned as part of broader therapeutic ecosystems rather than stand-alone products.

Collectively, these shifts are accelerating innovation cycles, raising the bar for clinical validation, and creating strategic pressure on incumbents and new entrants to demonstrate differentiated value across efficacy, ease of use, and total procedural efficiency. As a result, successful players are those that align product development with evolving care pathways and stakeholder expectations.

Analyzing how the cumulative tariff environment and trade policy adjustments in 2025 are reshaping supply chain resilience, procurement strategies, and pricing dynamics across stakeholders

Recent trade policy developments and tariff adjustments implemented in 2025 have introduced new variables into global supply chains for neurothrombectomy devices. The cumulative effects extend beyond immediate cost uplifts, influencing manufacturing footprint decisions, sourcing strategies for critical components, and the economics of cross-border distribution. In response, many manufacturers are reassessing supplier relationships and exploring nearshoring, dual sourcing, and increased inventory buffers to mitigate tariff-driven volatility. These shifts have downstream implications for procurement timelines and contractual terms with hospitals and distributors.

Hospitals and specialized centers confront a more complex procurement calculus where device pricing must be considered alongside service continuity and lead-time risks. In particular, institutions that rely on single-source distributors or just-in-time inventory models have had to renegotiate terms or adopt contingency stock strategies. Distributors facing margin compression are redefining their value proposition by offering bundled services, consignment models, or localized sterilization and logistics solutions to preserve competitiveness while absorbing incremental tariff-related costs.

Regulatory and reimbursement landscapes interact with tariff effects to shape adoption timing. Payers emphasize cost-effectiveness and long-term outcomes, thereby increasing scrutiny on claims of device superiority when acquisition costs rise. Consequently, manufacturers must present robust clinical and economic evidence to justify pricing during procurement negotiations. In sum, the tariff environment of 2025 has catalyzed strategic repositioning across manufacturing, distribution, and purchasing stakeholders, reinforcing the need for supply chain resilience and evidence-based pricing strategies.

Unpacking device, procedural, end-user and distribution segmentation nuances that determine clinical fit, procurement preferences, and commercial positioning across neurothrombectomy solutions

Segment-level dynamics reveal nuanced opportunities and constraints that vary by device type, procedural approach, end-user setting and distribution pathway. Within device type segmentation, aspiration catheters are further differentiated by bore size, with intermediate bore variants emphasizing flexibility and navigation in tortuous anatomy while large bore designs prioritize aspiration capacity for rapid clot removal. Combined systems occupy a spectrum from fully integrated platforms that pair aspiration and retrieval functions in a single workflow to standalone adjunct solutions that allow clinicians to combine best-in-class components during complex cases. Stent retrievers present their own segmentation between coated and uncoated designs, where surface treatments can influence clot-device interactions and deliverability profiles.

Procedure type segmentation reflects distinct clinical workflows and device performance expectations. Aspiration thrombectomy is often selected for cases where fast lumen recanalization via suction is feasible, whereas mechanical thrombectomy with retrievers is preferred when radial force and scaffold-based engagement are required. The combined approach can be executed sequentially-attempting aspiration first and then deploying a retriever if needed-or simultaneously, with complementary devices used in concert to maximize first-pass effect and minimize procedural time.

End-user segmentation also matters: ambulatory surgical centers demand streamlined, efficient systems with minimal ancillary equipment, whereas hospitals, including both comprehensive and primary stroke centers, require devices that integrate with diverse cath lab setups and support variable case complexity. Specialized neurology centers expect robust clinical evidence and training support to optimize outcomes. Distribution channel segmentation influences how products reach the point of care; direct sales models emphasize manufacturer-clinician relationships, e-commerce supports rapid replenishment for standard disposables, and third-party distributors-both independent and value-added-extend geographic reach while providing logistical and clinical training services.

Examining how regional differences across the Americas, Europe Middle East & Africa, and Asia-Pacific create distinct clinical, regulatory and commercial imperatives for device stakeholders

Regional patterns shape clinical practice, regulatory expectations, and commercial strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific, yielding distinct imperatives for market participants. In the Americas, established stroke networks and investment in comprehensive stroke centers have fostered rapid adoption of advanced thrombectomy devices, while broader geographic disparities continue to create demand for solutions that facilitate remote triage and transfer protocols. Consequently, suppliers often prioritize comprehensive service models, robust training programs, and evidence generation relevant to diverse health systems.

In Europe, Middle East & Africa, regulatory harmonization, reimbursement variation, and differing stroke care infrastructures create both opportunities and complexities. Multi-country regulatory pathways encourage modular product strategies and region-specific clinical engagement. Payment models that reward outcome-based care have incentivized manufacturers to generate localized real-world evidence. In parallel, healthcare systems across the region emphasize cost containment and value demonstration, which affects procurement timelines and tender structures.

Asia-Pacific exhibits heterogeneity in healthcare maturity, with leading markets investing heavily in stroke capabilities and emerging markets emphasizing scalable, cost-effective solutions. Rapid infrastructure expansion and growing specialist capacity are increasing demand for devices that combine clinical efficacy with supply reliability. Across all regions, strategic entrants tailor commercial approaches to local reimbursement mechanisms, training requirements, and logistical realities to maximize market relevance and adoption.

Evaluating how diverse company strategies, from global incumbents to specialized innovators and contract manufacturers, are shaping product roadmaps and competitive differentiation

Company-level dynamics reflect a spectrum of strategic postures ranging from large global medtech firms to nimble specialized developers and contract manufacturers. Established multinational players often leverage broad clinical trial programs, extensive distribution networks, and integrated service offerings to maintain position, while challengers focus on niche differentiation through improved deliverability, unique retrieval mechanisms, or combination therapies that target specific anatomical or clot composition challenges. In response to competitive pressure, alliances and targeted collaborations have grown more common as a way to accelerate time-to-market and expand clinical validation efforts.

Manufacturers are also reallocating R&D investment toward features that reduce procedure time and improve first-pass effect, since these outcomes resonate with clinicians and payers alike. At the same time, smaller innovators increasingly prioritize regulatory strategies that enable rapid entry in select regional markets with the intent to scale after initial clinical adoption. Contract manufacturing and strategic sourcing partners play a critical role in enabling capacity expansion and mitigating tariff exposure, prompting many companies to formalize supply chain risk management protocols.

Furthermore, service differentiation through training, procedural support, and data-driven post-market surveillance has emerged as a key competitive lever. Companies that effectively combine product innovation with accessible clinical education and longitudinal outcome tracking are better positioned to influence hospital formularies and gain clinician preference over time.

Practical, multi-stakeholder strategies to align product innovation, supply chain resilience and evidence-driven procurement for sustained clinical adoption and competitive advantage

Industry leaders should adopt a multi-dimensional strategy that aligns product innovation with supply chain robustness and stakeholder-centric commercial models. Manufacturers need to prioritize modular device portfolios that allow clinicians to tailor device selection to procedural complexity while maintaining economies of scale in production. Concurrently, diversifying supplier bases and exploring regional assembly or manufacturing hubs will reduce exposure to tariff-driven disruptions and improve responsiveness to local procurement cycles.

Clinicians and hospital procurement teams should strengthen clinician-led evaluation frameworks that emphasize real-world performance metrics, training support, and total procedural efficiency rather than focusing solely on unit price. This approach will facilitate informed purchasing decisions and enable better alignment with outcome-oriented reimbursement models. Distributors and channel partners must enhance their value proposition by offering logistics optimization, consignment models, and robust clinical training services that support device adoption and retention within varied care settings.

Finally, policymakers and payers should consider mechanisms that incentivize evidence generation, support equitable access to advanced stroke interventions, and encourage public-private collaboration to strengthen care networks. By implementing coordinated strategies across development, distribution, and clinical adoption, stakeholders can accelerate meaningful improvements in patient outcomes while sustaining commercial viability.

A layered research approach integrating clinical expert interviews, regulatory and procedural literature, and supply chain analysis to ensure validated and actionable insights

This research synthesizes qualitative and quantitative inputs using a layered methodology designed to balance clinical validity with operational realism. Primary research included structured interviews with interventional neuroradiologists, neurosurgeons, stroke program directors, hospital procurement officers, and distribution executives to capture procedural preferences, purchasing criteria, and supply chain constraints. Secondary research encompassed peer-reviewed clinical studies, regulatory filings, device labeling, and publicly available procedural guidelines to corroborate clinical performance claims and practice patterns.

Analysts triangulated insights with device registries, conference proceedings, and manufacturer technical documentation to identify recurring trends in device iteration, procedural outcomes, and training practices. Supply chain analysis incorporated vendor mapping, component sourcing reviews, and logistics assessments to highlight tariff sensitivities and lead-time vulnerabilities. Where appropriate, findings were validated through follow-up expert consultations to ensure conclusions reflect current clinical practice and operational realities.

Limitations inherent to market research were acknowledged and mitigated: proprietary pricing arrangements and confidential procurement contracts constrain visibility into certain commercial terms, and rapidly evolving clinical evidence can shift practice patterns. To address these limitations, the methodology emphasizes transparent sourcing, conservative inference where data are incomplete, and recommendations that prioritize adaptability and ongoing evidence collection.

Concluding synthesis highlighting how clinical performance, operational resilience, and evidence-based commercialization determine long-term success in neurothrombectomy

The conclusion distills how technological innovation, procedural evolution, and recent trade dynamics collectively influence strategic decision-making across the neurothrombectomy ecosystem. Devices that deliver demonstrable improvements in first-pass effect, ease of navigation, and cross-platform compatibility will retain a competitive edge as care pathways emphasize rapid reperfusion and streamlined workflows. At the same time, tariff-induced supply chain pressures have underscored the importance of manufacturing agility, diversified sourcing, and value-added distribution models in maintaining service continuity.

Region-specific considerations and end-user priorities demand tailored commercial strategies, while robust clinical evidence and post-market performance tracking remain decisive in procurement deliberations. Companies that combine focused product differentiation with comprehensive clinician training and outcome transparency are most likely to win sustained adoption. Meanwhile, hospitals and health systems that align purchasing decisions with long-term outcome metrics can better justify investments in advanced devices despite short-term cost pressures.

In closing, stakeholders that proactively integrate clinical, operational, and commercial dimensions into cohesive strategies will be best positioned to deliver improved patient outcomes and realize durable competitive advantage as the neurothrombectomy field continues to mature.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Neurothrombectomy Devices Market, by Device Type

  • 8.1. Aspiration Catheters
    • 8.1.1. Intermediate Bore
    • 8.1.2. Large Bore
  • 8.2. Combined Systems
    • 8.2.1. Integrated System
    • 8.2.2. Standalone Adjunct
  • 8.3. Stent Retrievers
    • 8.3.1. Coated
    • 8.3.2. Uncoated

9. Neurothrombectomy Devices Market, by Procedure Type

  • 9.1. Aspiration Thrombectomy
  • 9.2. Combined Approach
    • 9.2.1. Sequential
    • 9.2.2. Simultaneous
  • 9.3. Mechanical Thrombectomy

10. Neurothrombectomy Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
    • 10.2.1. Comprehensive Stroke Centers
    • 10.2.2. Primary Stroke Centers
  • 10.3. Specialized Neurology Centers

11. Neurothrombectomy Devices Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. E Commerce
  • 11.3. Third Party Distributor
    • 11.3.1. Independent Distributor
    • 11.3.2. Value Added Distributor

12. Neurothrombectomy Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Neurothrombectomy Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Neurothrombectomy Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Neurothrombectomy Devices Market

16. China Neurothrombectomy Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Acandis GmbH & Co. KG
  • 17.6. Boston Scientific Corporation
  • 17.7. Imperative Care, Inc.
  • 17.8. Johnson & Johnson
  • 17.9. Medtronic plc
  • 17.10. Penumbra, Inc.
  • 17.11. Phenox GmbH
  • 17.12. Rapid Medical Ltd.
  • 17.13. Stryker Corporation
  • 17.14. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTERMEDIATE BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY LARGE BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STANDALONE ADJUNCT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY UNCOATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION THROMBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SEQUENTIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SIMULTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMPREHENSIVE STROKE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRIMARY STROKE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SPECIALIZED NEUROLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY E COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY INDEPENDENT DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VALUE ADDED DISTRIBUTOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 185. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 186. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 188. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 189. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 190. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 192. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. GCC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 218. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 221. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 222. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 223. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 225. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 227. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. G7 NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 229. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 232. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 233. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 234. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 236. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 238. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. NATO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STENT RETRIEVERS, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COMBINED APPROACH, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THIRD PARTY DISTRIBUTOR, 2018-2032 (USD MILLION)